Positive preliminary results from ATL1102 for DMD Phase II trial

Author's Avatar
Sep 18, 2019
Article's Main Image

- Data Safety Monitoring Board recommends continuation of the trial with no safety concerns

- Preliminary data from 6 month dosing is indicative of positive drug effect at dose tested

PR Newswire